Results 141 to 150 of about 40,743 (286)

Tratamiento con SSRI durante el embarazo: un caso clínico

Los SSRI como clase farmacológica no se asocian de manera consistente con un aumento del riesgo de malformaciones congénitas por encima del riesgo basal.
Amanda Koire
core   +1 more source

Salivary Viscosity as a Non‐Invasive Candidate Biomarker Associated With Aspiration Risk in Oculopharyngeal Muscular Dystrophy

Journal of Oral Rehabilitation, EarlyView.
Patients with oculopharyngeal muscular dystrophy exhibit disease‐specific salivary hyperviscosity that tracks with dysphagia severity and airway invasion. Non‐invasive chairside screening of salivary viscosity may enable clinicians to stratify aspiration risk during routine care to prevent severe pulmonary complications.
Alex Zvulunov, Rawan Saif, Liraz Olmer, Merav Ben‐David, Limor Benyamini, Amir Dori, Noam Yarom, Lior Greenbaum, Ephraim Tzur, Silvina Friedlander‐Barenboim   +9 more
wiley   +1 more source

Sex-based Differences in the Efficacy and Tolerability of Selective Serotonin Reuptake Inhibitors in Adults with Major Depressive Disorder: A Systematic Review and Meta-analysis. [PDF]

Indian J Psychol Med
Pandey AK, Tiwary A, Khan FA, Reyazudin M, Khan IA.   +4 more
europepmc   +1 more source

CHARGE Syndrome: A Narrative Review and Update on Diagnosis, Assessment and Management

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background CHARGE syndrome (CS) is a rare multisystemic genetic condition caused by a pathogenic variant in the DNA‐binding protein‐7 CHD7 gene. The condition affects the development of neural crest cells, which give rise to craniofacial structures, cranial nerves, ears, eyes and the heart, resulting in diverse and complex clinical features ...
Eleni M. van Gelder, Suzanna E. L. Temple, Niall Jefferson, David Brown, Kasee Stratton‐Gadke, Madelene Rich, Steve Rose, Kim Blake   +7 more
wiley   +1 more source

Weight Gain During SSRI Therapy: The Potential Role of the Gut Microbiota-A Narrative Review and Mechanistic Hypothesis. [PDF]

Nutrients
Śnieżek J, Polak-Szczybyło E.
europepmc   +1 more source

Dawkowanie SSRI w OCD: poza wytycznymi FDA

Próba terapeutyczna w OCD wymaga utrzymania maksymalnej dawki SSRI przez co najmniej 12 do 16 tygodni. W tym okresie należy unikać strategii augmentacji.
Robert Hudak
core   +1 more source

Clinical Symptomatology, Cognition and Psychosocial Wellbeing in Adolescents With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Cross‐Sectional Observational Study

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling illness that frequently begins in adolescence, yet adolescents with ME/CFS remain an under‐researched population. We aimed to characterise the cognitive and psychosocial wellbeing of adolescents with ME/CFS relative to normative benchmarks and unaffected age‐peers ...
Tracey Chau, Elisha K. Josev, Adam Scheinberg, Natalie Thomas, Fiona McDonald, Colette Reveley, Paul R. Gooley, Christopher Armstrong, Sarah Knight   +8 more
wiley   +1 more source

Perioperative Selective Serotonin Reuptake Inhibitor (SSRI) Use and Postoperative Fracture Fixation Outcomes: A Multi-institutional Retrospective Cohort Study. [PDF]

Cureus
Ponna A, Soma S, Demetriou ZJ, Giakas A, Ilyas AM.   +4 more
europepmc   +1 more source

SSRI Augmentasyonu Doz Optimizasyonundan Üstün müdür?

Yetersiz SSRI yanıtı olan hastalarda alternatif stratejiler (augmentasyon, ilaç değişimi, psikoterapi), altı hafta sonunda yanıt olasılığını doz optimizasyonuna kıyasla iki katına çıkardı (%28'e karşı %14). Stratejiler arasında etkinlik açısından anlamlı
Paul Zarkowski
core   +1 more source

Concurrent Use of Tasipimidine Oral Solution and Fluoxetine in Dogs

Journal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT This exploratory randomized crossover study investigated pharmacokinetic interactions, functional alertness, and cardiovascular safety of tasipimidine oral solution administered alone and in combination with fluoxetine in healthy Beagle dogs (n = 8; 4 dogs per dose level), with a 7‐day washout between phases. Dogs received single oral doses of
Jenni Lindstedt, Jouko M. Levijoki, Johanna Tuunainen, Jens Häggström, Meri Ramela, Mira Korpivaara   +5 more
wiley   +1 more source